Clinical Trials Directory

Trials / Conditions / CNS Lymphoma

CNS Lymphoma

19 registered clinical trials studyying CNS Lymphoma — 9 currently recruiting.

StatusTrialSponsorPhase
RecruitingZanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma
NCT06730542
Juan P. Alderuccio, MDPhase 1
Not Yet RecruitingMethotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients
NCT06901999
Ruijin HospitalPhase 2
CompletedPhase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
NCT06322342
Reveal Pharmaceuticals Inc.Phase 2
RecruitingT-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT06343311
Estrella Biopharma, Inc.Phase 1 / Phase 2
RecruitingRelma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma
NCT06876688
Ruijin HospitalPhase 2
Recruiting[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients
NCT06132737
Pentixapharm AGPhase 1 / Phase 2
RecruitingCLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
NCT05828628
Royal Marsden NHS Foundation Trust—
RecruitingOrelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With C
NCT05926427
Ruijin HospitalPhase 2
Terminated[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
NCT05222269
Pentixapharm AGPhase 2
RecruitingTafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
NCT05351593
James RubensteinPhase 1 / Phase 2
TerminatedGB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma
NCT05242146
GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.Phase 1
RecruitingPreliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
NCT05098613
University of Colorado, DenverPhase 1
UnknownZanubrutinib Monotherapy in Relapsed/Refractory Central Nervous System Lymphoma
NCT05117814
Peking University People's HospitalN/A
CompletedA Phase I/II Study to Investigate the Use of VORAXAZE™ As Intended Intervention in Patients with CNSL
NCT04841434
Charite University, Berlin, GermanyPhase 1 / Phase 2
CompletedUsefulness of Gadovist-enhanced FLAIR Imaging
NCT05293990
Ryoo, In SeonN/A
CompletedComparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate
NCT01319591
Dana-Farber Cancer Institute—
CompletedHigh Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lym
NCT01182415
Massachusetts General HospitalPhase 2
CompletedHigh-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabin
NCT01083342
Samsung Medical CenterPhase 2
CompletedRituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-
NCT00596154
Memorial Sloan Kettering Cancer CenterPhase 2